NewsRx

Search our medical news database

Stem-Cell Transplantation

Auto-SCT complications more extensive during hematological cancer

Published in Blood Weekly, January 29th, 2004

Hematological cancer patients suffer from more extensive complications after HDC+auto-SCT compared to patients with solid tumors.

According to recent research from Italy, "Multiple factors contribute to transplant-related complications after high-dose chemotherapy followed by autologous peripheral blood stem-cell transplantation, including conditioning regimens, number of infused stem cells and clinical characteristics of patient at transplant."

M. Martino and coauthors working at Azienda Ospedaliera Bianchi-Melacrino-Morelli "compared the transplant-related complications of 141 patients affected with hematological malignancies with those of 109...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook